1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

Cell lines tested with tanespimycin:bortezomib (250:1 mol/mol)

797 cell lines have been tested with this compound, using data from 1 dataset(s).
SNU-489 central nervous system CTRPv21
SIMA autonomic ganglia CTRPv21
SNU-245 biliary tract CTRPv21
HDQ-P1 breast CTRPv21
ALL-SIL haematopoietic and lymphoid tissue CTRPv21
253J urinary tract CTRPv21
RPMI-7951 skin CTRPv21
NMC-G1 central nervous system CTRPv21
HuCCT1 biliary tract CTRPv21
CAL-62 thyroid CTRPv21
Download CSV

Tissues tested with tanespimycin:bortezomib (250:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
lungCTRPv2142
haematopoietic and lymphoid tissueCTRPv2135
N/ACTRPv247
central nervous systemCTRPv245
skinCTRPv244
pancreasCTRPv240
large intestineCTRPv239
ovaryCTRPv238
breastCTRPv237
stomachCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SMKR1 CTRPv2 AAC -2.4e-06 1
mRNA PIGR CTRPv2 AAC 1.1e-06 1
Download CSV